Abdomen Flashcards

(44 cards)

1
Q

How is haemochromatosis inherited?

A

Autosomal recessive

Inheritance of mutated HFE gene

(however there is variable penetrance - so presence of mutation doesn’t always lead to disease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Investigations in haemochromatosis

A

Bedside:
- ECG: arrhythmia (from cardiomyopathy)
- Urine: glycosuria

Bloods:
- FBC (usually normal)
- LFTs, albumin, INR
- Ferritin and transferrin (both raised)
- HbA1c
- Genotyping

Imaging:
- US liver
- Fibroscan
- Ferriscan (specialised MRI)
- Echo to assess cardiomyopathy
- Plain films of affected joints

Liver biopsy not needed!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Management of haemochromatosis

A

MDT - Hepatology +/- haematology

Venesection
- Initiation to bring transferrin to an acceptable level
- Then maintenance venesection

Management of complications:
- T2DM
- Cardiomyopathy
- Cirrhosis (diuresis, HCC screening, nutrition etc)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Causes of haemochromatosis

A

Primary = hereditary haemochromatosis

Secondary = acquired haemochromatosis
- Seen in multiple transfusions e.g. haemoglobinopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Hereditary haemchromatosis: examination

A

Tanned skin

CBG monitor

CLD signs

May have hepatomegaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Hereditary spherocytosis - presentation

A

Splenomegaly
Anaemia -> fatigue
Gallstone
Leg ulceration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mechanism of haemolysis in hereditary spherocytosis

A

Abnormal protein coding resulting in spherical RBCs (instead of biconcave)

These cells are prone to haemolysis, especially in the spleen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hereditary spherocytosis inheritance

A

autosomal dominant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

splenomegaly DDx

A

Massive spleen:
- CML
- Myelofibrosis
- Malaria

Otherwise:
1) Lymphocytosis
- Lymphoma (acute or chronic)
- Reactive (infection eg EBV)

2) Extra-medullary haematopoiesis
- Chronic haemolytic anaemia eg hereditary spherocytosis

3) Inflammatory
- Felty’s syndrome (RA + splenomegaly + neutropenia)
- Amyloidosis (infiltrative)

4) Congestive
- Portal hypertension (usually with hepatomegaly)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Complications of hereditary spherocytosis

A
  • Gallstones
  • Chronic anaemia
  • Aplastic anaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Investigations in hereditary spherocytosis

A
  • FBC, U+Es, CRP, LFTs
  • Blood film
  • Split bilirubin

Haemolysis screen:
- increased reticulocytes
- raised LDH
- low haptoglobin
- normal DAT

Specific testing:
- EMA binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hereditary spherocytosis management

A
  • Folic acid supplementation
  • RBCs as needed

Severe cases:
- Splenectomy, typically with cholecystectomy
- Vaccinations again encapsulated organisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Coeliac disease - investigations

A

Diagnostic:
- Anti-TTG antibodies with IgA levels
-can have false negative if IgA deficiency
-need to eat gluten for preceding 6 weeks
- If equivocal result - proceed to duodenal biopsy
- villous atrophy and crypt hypertrophy

General testing:
- FBC, U+Es, CRP, LFTs
- B12, folate, vitamin D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Coeliac disease: management

A

Patient education is key
Gluten eradication from diet (refer to dietitian)

Support with iron, B12 and vitamin D supplementation if needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Complications of coeliac disease

A
  • Iron def anaemia
  • B12, folate, vitamin D deficiency
  • Functional hyposplenism (need winter vaccinations)
  • Malignancies: enteropathy-associated T-cell lymphoma and small bowel cancer
  • Skin: dermatitis herpetiformis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When is simultaneous pancreas-kidney transplant typically performed?

A

Usually T1DM

Where diabetes has led to end stage renal failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Graft choice in SPK

A

Usually the pancreas and kidney are both donated from a single deceased donor (usually brainstem death)

Can also be pancreas transplant from a deceased donor + kidney transplant from a live donor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

SPK - examination

A

Midline laparotomy scar AND Rutherford-morrison scar

There may be 2 Rutherford Morrison scars, usually pancreas in LIF but usually this wouldnt be palpable

19
Q

Serum ascites albumin gradient interpretation

A

SAAG >1.1g/L = portal hypertension
- Cirrhosis
- Congestive cardiac failure

SAAG <1.1g/L
- Nephrotic syndrome
- Malignancy
- Pancreatitis
- Infection e.g. TB

20
Q

Non invasive liver screen

A

Viral serology
- Hep B surface antigen
- Hep C antibody (IgG)
- Hep D
- Hep A and E - acute hepatitis

Autoimmune profile:
- ANA, AMA, anti-smooth muscle, anti-LKM
- Immunoglobulins

Metabolic screen:
- Ferritin and transferrin sats
- Raised copper and low caeruloplasmin
- Alpha 1 antitrypsin

21
Q

PSC investigations and management

A

Investigations:
- Typically normal antibodies
- Can be p-ANCA +ve
- Cholestatic LFTs with characteristic strictures on MRCP giving a ‘beaded’ appearance
- Autoimmune screen: coeliac, thyroid
- Imaging: US liver, MRCP

Management:
- UDCA
- ERCP and stenting of strictures
- Colonoscopy for malignancy screening
- HCC monitoringAN

22
Q

PBC investigations and management

A

Investigations:
- Cholestatic LFTs and AMA +ve
- US liver
- Consider MRCP
- Fibroscan
- Send thyroid, coeliac and sjogrens screen

Management
- UDCA
- If not responding, refer to tertiary centre for consideration of 2nd line agents e.g. OCA, BF

23
Q

Causes of palpable liver transplant

A

Size mismatch

Hepatitis - graft dysfunction (tender edge)

24
Q

Causes of splenomegaly

A

Massive: 5 M’s
- Myelofibrosis
- CML
- AML
- Malaria
- leishManiasis

Moderate:
- Myeloproliferative: AML, CML
- Lymphoproliferative: ALL, CLL
- Congestive (portal hypertension)
- Inflammatory e.g. amyloidosis

Mild:
- Haemolysis e.g. hereditary spherocytosis
- Infection e.g. EBV, bacterial endocarditis
- Inflammatory e.g. SLE

25
Important negative in splenomegaly
- Clinical anaemia - Clinical jaundice - Lympadenopathy
26
Splenectomy indications
1) Trauma/splenic haemorrhage 2) Chronic haemolytic states e.g. thalassemia major, hereditary spherocytosis 3) ITP refractory to medical management
27
Splenectomy complications
Peri-operative complications: - Bleeding - Infection - Damage to surrounding structures Post-operative: - Thrombocytosis - Overwhelming sepsis from encapsulated organisms
28
How to prevent complications in splenectomy patients
Pre-operative: - Vaccinations >2 weeks prior to surgery - Prophylactic Abx Post-operative: - Patient education (attend hospital early if unwell) - Medic alert bracelet - Prophylactic Abx - Vaccines e.g. pneumovax
29
General management of CKD
1) Treat underlying cause: - Control HTN, diabetes - Remove nephrotoxic agents - Treat glomerulonephritis where possible 2) Complications: - Hypertension - Hypervolaemia - Electrolyte and acid-base disturbance - Renal bone disease - Renal anaemia - Increased CVD risk 3) End-stage renal failure - RRT: Haemodialysis, peritoneal dialysis, renal transplant - 4-variable kidney risk factor gives 5-year probability of requiring RRT 4) Patient education - Weight loss - Smoking cessation - Dietitians - low salt/potassium diet - vaccinations
30
Pharmacological management of CKD
Hypertension: ACEi Hypervolaemia: diuretics (furosemide) Electrolyte disturbance: potassium binder, phosphate binder Renal bone disease: activated vitamin D, DEXA monitoring Renal anaemia: iron replacement, EPO if affecting QOL Cardiovascular risk: statin and anti-platelet Also - Stop nephrotoxics where possible - Adjust meds to renal dosing
31
Nephrectomy indications
- Debulking surgery - RCC - Recurrent infections - Significant haematuria
32
Management of PKD
- Monitoring for CKD and treating complications - Tolvaptan (vasopressin receptor antagonist) - Consider RRT - Monitoring and assessment of complications e.g. saccular aneurysms, SAH
33
Emergency indications for surgery in IBD
Toxic megacolon Colonic perforation Intra-abdominal abscess (if severely septic)
34
Management of ascites
Fluid restriction Low salt diet Diuretics Large volume paracentesis TIPSS Transplant
34
Non invasive liver screen
LFTs incl. synthetic function (albumin, clotting) Viral hepatitis serology + HIV Autoimmune - ANA, AMA (PBC) - ANCA (PSC) - SMA/LKM1 (AIH) - Immunoglobulins - A1AT Metabolic: - Ferritin and transferrin sats - Copper, caeruloplasmin - HbA1c and lipids
35
Complications of TIPSS
Hepatic encephalopathy Pulmonary HTN
36
Bilateral renal masses DDx
Polycystic kidneys Bilateral hydronephrosis Bilateral renal massess e.g. angiomyolipoma in Tuberous Sclerosis
37
Extra-hepatic complications of alcohol excess
Neuro: - Cerebellar ataxia - Alcohol-related brain damage - Wernicke's encephalopathy - Korsakoff's syndrome - Peripheral neuropathy Cardiac: - Dilated cardiomyopathy HPB/GI: - Pancreatitis - Malnutrition
38
Prognostic scores in CLD
Child-Pugh score UKELD
39
Causes of gynaecomastia
Idiopathic Drugs: - Spironolactone - Digoxin - Anabolic steroids Chronic liver disease Hyperthyroidism Geneic e.g. Klinefelters syndrome
40
If you see a stoma in the lower left abdomen (not a colostomy)?
Could be a mucus fistula stoma This is done to allow mucus to pass from disconnected bowel
41
Risk stratification of needing RRT
4-variable kidney failure risk score Gives probability of needing RRT in next 5 years
42
Management of ulcerative colitis
ASUC: - Bowel rest - IV hydrocortisone Maintenance: - Mild-moerate: 5-ASA analogues e.g. mesalazine - AZT - Biologics e.g. infliximab - Surgical resection
43
Functions of the spleen
Lymphocytosis (honorary lymph node) Extra-medullary haemopoiesis